close
    Is drug callked Ampyra approved by FDA for treatment of walking of MS patients?

    0  Views: 204 Answers: 1 Posted: 12 years ago

    1 Answer

    For Immediate Release: Jan. 22, 2010
    Contact: Sandy Walsh, 301-796-4669, sandy.walsh@fda.hhs.gov
    Consumer Inquiries: 888-INFO-FDA

    FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis

    The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.


    Top contributors in Uncategorized category

     
    ROMOS
    Answers: 18061 / Questions: 154
    Karma: 1101K
     
    Colleen
    Answers: 47271 / Questions: 115
    Karma: 953K
     
    country bumpkin
    Answers: 11322 / Questions: 160
    Karma: 838K
     
    Benthere
    Answers: 2392 / Questions: 30
    Karma: 760K
    > Top contributors chart
    450233
    questions
    718940
    answers
    743088
    users